Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-19

Clinical Trial Update: SCRATCH-HTN Study: Evaluating Autonomic Neuromodulation Using Trans-cutaneous Vagal Stimulation in Hypertensive Patients [NA]

View source ↗

Summary

The SCRATCH-HTN trial evaluating trans-cutaneous vagal nerve stimulation as autonomic neuromodulation for hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Queen Mary University of London | Conditions: Uncontrolled Hypertension, High Blood Pressure | NA | Status: COMPLETED